Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

6.61USD
23 Sep 2016
Change (% chg)

-- (--)
Prev Close
$6.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,720
52-wk High
$13.50
52-wk Low
$5.49

Select another date:

Thu, Sep 22 2016

BRIEF-Rockwell Medical anticipates Calcitriol to be available in U.S. in approximately 45 days

* Anticipates Calcitriol will become commercially available in U.S. in approximately 45 days Source text for Eikon: Further company coverage:

BRIEF-Rockwell Medical enters into license agreement with ARAM Medical

* Rockwell Medical enters into exclusive license agreement with ARAM Medical to commercialize Triferic in Saudi Arabia, Egypt and Middle East territories

BRIEF-Rockwell Medical Inc - qtrly sales were $13.5 mln, or 3.8% higher than Q2 2015

* Qtrly sales were $13.5 million, or 3.8% higher than q2 2015. Source text for Eikon: Further company coverage:

BRIEF-Rockwell Medical votes to expand size of board

* Says Robin L. Smith appointed director Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-Rockwell Medical gets international trademark approvals for Triferic

* Rockwell Medical announces multiple international trademark approvals for Triferic Source text for Eikon: Further company coverage:

BRIEF-Rockwell Medical Q1 loss per share $0.10

* Q1 earnings per share view $-0.08, revenue view $15.2 million -- Thomson Reuters I/B/E/S

BRIEF-Rockwell Medical provides update on preparations for Calcitriol commercial launch

* Rockwell medical provides update on preparations for Calcitriol commercial launch

BRIEF-U.S. FDA approves Rockwell's triferic powder packet

* U.S. FDA approves Rockwell's triferic powder packet for treating anemia in hemodialysis patients

Select another date: